189 related articles for article (PubMed ID: 18496560)
41. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
[TBL] [Abstract][Full Text] [Related]
42. Ex vivo expansion of retrovirally transduced primate CD34+ cells results in overrepresentation of clones with MDS1/EVI1 insertion sites in the myeloid lineage after transplantation.
Sellers S; Gomes TJ; Larochelle A; Lopez R; Adler R; Krouse A; Donahue RE; Childs RW; Dunbar CE
Mol Ther; 2010 Sep; 18(9):1633-9. PubMed ID: 20571542
[TBL] [Abstract][Full Text] [Related]
43. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
[TBL] [Abstract][Full Text] [Related]
44. Leukemogenesis of the EVI1/MEL1 gene family.
Morishita K
Int J Hematol; 2007 May; 85(4):279-86. PubMed ID: 17483069
[TBL] [Abstract][Full Text] [Related]
45. Activation of Evi1 inhibits cell cycle progression and differentiation of hematopoietic progenitor cells.
Kustikova OS; Schwarzer A; Stahlhut M; Brugman MH; Neumann T; Yang M; Li Z; Schambach A; Heinz N; Gerdes S; Roeder I; Ha TC; Steinemann D; Schlegelberger B; Baum C
Leukemia; 2013 Apr; 27(5):1127-38. PubMed ID: 23212151
[TBL] [Abstract][Full Text] [Related]
46. Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy.
Davé UP; Akagi K; Tripathi R; Cleveland SM; Thompson MA; Yi M; Stephens R; Downing JR; Jenkins NA; Copeland NG
PLoS Genet; 2009 May; 5(5):e1000491. PubMed ID: 19461887
[TBL] [Abstract][Full Text] [Related]
47. Globin lentiviral vector insertions can perturb the expression of endogenous genes in beta-thalassemic hematopoietic cells.
Hargrove PW; Kepes S; Hanawa H; Obenauer JC; Pei D; Cheng C; Gray JT; Neale G; Persons DA
Mol Ther; 2008 Mar; 16(3):525-33. PubMed ID: 18195719
[TBL] [Abstract][Full Text] [Related]
48. Hematopoietic immortalizing function of the NKL-subclass homeobox gene TLX1.
Zweier-Renn LA; Hawley TS; Burkett S; Ramezani A; Riz I; Adler RL; Hickstein DD; Hawley RG
Genes Chromosomes Cancer; 2010 Feb; 49(2):119-31. PubMed ID: 19862821
[TBL] [Abstract][Full Text] [Related]
49. Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials.
Will E; Bailey J; Schuesler T; Modlich U; Balcik B; Burzynski B; Witte D; Layh-Schmitt G; Rudolph C; Schlegelberger B; von Kalle C; Baum C; Sorrentino BP; Wagner LM; Kelly P; Reeves L; Williams DA
Mol Ther; 2007 Apr; 15(4):782-91. PubMed ID: 17299409
[TBL] [Abstract][Full Text] [Related]
50. Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design.
Maruggi G; Porcellini S; Facchini G; Perna SK; Cattoglio C; Sartori D; Ambrosi A; Schambach A; Baum C; Bonini C; Bovolenta C; Mavilio F; Recchia A
Mol Ther; 2009 May; 17(5):851-6. PubMed ID: 19293778
[TBL] [Abstract][Full Text] [Related]
51. Reducing the genotoxic potential of retroviral vectors.
Ramezani A; Hawley TS; Hawley RG
Methods Mol Biol; 2008; 434():183-203. PubMed ID: 18470646
[TBL] [Abstract][Full Text] [Related]
52. An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation.
Ryu BY; Evans-Galea MV; Gray JT; Bodine DM; Persons DA; Nienhuis AW
Blood; 2008 Feb; 111(4):1866-75. PubMed ID: 17991809
[TBL] [Abstract][Full Text] [Related]
53. Retroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways.
Kustikova OS; Geiger H; Li Z; Brugman MH; Chambers SM; Shaw CA; Pike-Overzet K; de Ridder D; Staal FJ; von Keudell G; Cornils K; Nattamai KJ; Modlich U; Wagemaker G; Goodell MA; Fehse B; Baum C
Blood; 2007 Mar; 109(5):1897-907. PubMed ID: 17119121
[TBL] [Abstract][Full Text] [Related]
54. Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis.
Modlich U; Kustikova OS; Schmidt M; Rudolph C; Meyer J; Li Z; Kamino K; von Neuhoff N; Schlegelberger B; Kuehlcke K; Bunting KD; Schmidt S; Deichmann A; von Kalle C; Fehse B; Baum C
Blood; 2005 Jun; 105(11):4235-46. PubMed ID: 15713797
[TBL] [Abstract][Full Text] [Related]
55. A self-inactivating gamma-retroviral vector reduces manifestations of mucopolysaccharidosis I in mice.
Metcalf JA; Ma X; Linders B; Wu S; Schambach A; Ohlemiller KK; Kovacs A; Bigg M; He L; Tollefsen DM; Ponder KP
Mol Ther; 2010 Feb; 18(2):334-42. PubMed ID: 19844196
[TBL] [Abstract][Full Text] [Related]
56. Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes.
Zhou S; Fatima S; Ma Z; Wang YD; Lu T; Janke LJ; Du Y; Sorrentino BP
Mol Ther; 2016 Jun; 24(6):1090-1099. PubMed ID: 26957223
[TBL] [Abstract][Full Text] [Related]
57. Retroviral Insertional Mutagenesis in Humans: Evidence for Four Genetic Mechanisms Promoting Expansion of Cell Clones.
Bushman FD
Mol Ther; 2020 Feb; 28(2):352-356. PubMed ID: 31951833
[TBL] [Abstract][Full Text] [Related]
58. V-myc in a simple, single gene retroviral vector causes rapid induction of leukemia and concomitant apoptosis following bone marrow transplantation.
Dolnikov A; Shounan Y; Millington M; Mackenzie K; Symonds G
Leukemia; 1998 Apr; 12(4):542-53. PubMed ID: 9557613
[TBL] [Abstract][Full Text] [Related]
59. In vitro analysis of transformation potential associated with retroviral vector insertions.
Powell SK; Kaloss M; Burimski I; Weaver L; Long Z; Lyons R; McGarrity GJ; Otto E
Hum Gene Ther; 1999 Sep; 10(13):2123-32. PubMed ID: 10498244
[TBL] [Abstract][Full Text] [Related]
60. Biosafety of onco-retroviral vectors.
VandenDriessche T; Collen D; Chuah MK
Curr Gene Ther; 2003 Dec; 3(6):501-15. PubMed ID: 14683449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
